Works by Bianchini, Giampaolo

Results: 42
    1
    2
    3

    Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf088
    By:
    • Valsecchi, Anna Amela;
    • Pisegna, Simona;
    • Antonuzzo, Andrea;
    • Arpino, Grazia;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Colloca, Giuseppe Ferdinando;
    • Criscitiello, Carmen;
    • Danesi, Romano;
    • Fabi, Alessandra;
    • Giusti, Raffaele;
    • Pau, Loredana;
    • Maio, Massimo Di;
    • Santini, Daniele
    Publication type:
    Article
    4

    Development and validation of a gene expression-based Breast Cancer Purity Score.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00730-7
    By:
    • Barreca, Marco;
    • Dugo, Matteo;
    • Galbardi, Barbara;
    • Győrffy, Balázs;
    • Gianni, Luca;
    • Bisagni, Giancarlo;
    • Colleoni, Marco;
    • Del Mastro, Lucia;
    • Zamagni, Claudio;
    • Mansutti, Mauro;
    • Zambetti, Milvia;
    • Frassoldati, Antonio;
    • Montemurro, Filippo;
    • Bengala, Carmelo;
    • Mariani, Gabriella;
    • Gambaro, Anna;
    • Zambelli, Stefania;
    • Bianchini, Giampaolo;
    • Russo, Stefania;
    • Huang, Chiun-Sheng
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 3, p. 264, doi. 10.1093/jnci/djq524
    By:
    • Iwamoto, Takayuki;
    • Bianchini, Giampaolo;
    • Booser, Daniel;
    • Yuan Qi;
    • Coutant, Charles;
    • Shiang, Christine Ya-Hui;
    • Santarpia, Libero;
    • Matsuoka, Junji;
    • Hortobagyi, Gabriel N.;
    • Symmans, William Fraser;
    • Holmes, Frankie A.;
    • O'Shaughnessy, Joyce;
    • Hellerstedt, Beth;
    • Pippen, John;
    • Andre, Fabrice;
    • Simon, Richard;
    • Pusztai, Lajos
    Publication type:
    Article
    12
    13
    14
    15
    16

    Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review.

    Published in:
    Cancers, 2022, v. 14, n. 8, p. 1898, doi. 10.3390/cancers14081898
    By:
    • Garutti, Mattia;
    • Griguolo, Gaia;
    • Botticelli, Andrea;
    • Buzzatti, Giulia;
    • De Angelis, Carmine;
    • Gerratana, Lorenzo;
    • Molinelli, Chiara;
    • Adamo, Vincenzo;
    • Bianchini, Giampaolo;
    • Biganzoli, Laura;
    • Curigliano, Giuseppe;
    • De Laurentiis, Michelino;
    • Fabi, Alessandra;
    • Frassoldati, Antonio;
    • Gennari, Alessandra;
    • Marchiò, Caterina;
    • Perrone, Francesco;
    • Viale, Giuseppe;
    • Zamagni, Claudio;
    • Zambelli, Alberto
    Publication type:
    Article
    17
    18

    PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials.

    Published in:
    Cancers, 2021, v. 13, n. 14, p. 3571, doi. 10.3390/cancers13143571
    By:
    • Di Micco, Rosa;
    • Santurro, Letizia;
    • Gasparri, Maria Luisa;
    • Zuber, Veronica;
    • Cisternino, Giovanni;
    • Baleri, Sara;
    • Morgante, Manuela;
    • Rotmensz, Nicole;
    • Canevari, Carla;
    • Gallivanone, Francesca;
    • Scifo, Paola;
    • Savi, Annarita;
    • Magnani, Patrizia;
    • Neri, Ilaria;
    • Ferjani, Nadia;
    • Venturini, Elena;
    • Losio, Claudio;
    • Sassi, Isabella;
    • Bianchini, Giampaolo;
    • Panizza, Pietro
    Publication type:
    Article
    19
    20
    21
    22

    Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID‐19 Outbreak.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. e1013, doi. 10.1634/theoncologist.2020-0316
    By:
    • Viale, Giulia;
    • Licata, Luca;
    • Sica, Lorenzo;
    • Zambelli, Stefania;
    • Zucchinelli, Patrizia;
    • Rognone, Alessia;
    • Aldrighetti, Daniela;
    • Di Micco, Rosa;
    • Zuber, Veronica;
    • Pasetti, Marcella;
    • Di Muzio, Nadia;
    • Rodighiero, Mariagrazia;
    • Panizza, Pietro;
    • Sassi, Isabella;
    • Petrella, Giovanna;
    • Cascinu, Stefano;
    • Gentilini, Oreste Davide;
    • Bianchini, Giampaolo
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2011, v. 125, n. 3, p. 785, doi. 10.1007/s10549-010-1280-6
    By:
    • Iwamoto, Takayuki;
    • Bianchini, Giampaolo;
    • Qi, Yuan;
    • Cristofanilli, Massimo;
    • Lucci, Anthony;
    • Woodward, Wendy;
    • Reuben, James;
    • Matsuoka, Junji;
    • Gong, Yun;
    • Krishnamurthy, Savitri;
    • Valero, Vicente;
    • Hortobagyi, Gabriel;
    • Robertson, Fredika;
    • Symmans, W.;
    • Pusztai, Lajos;
    • Ueno, Naoto
    Publication type:
    Article
    29

    Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.

    Published in:
    2013
    By:
    • Bianchini, Giampaolo;
    • Pusztai, Lajos;
    • Karn, Thomas;
    • Iwamoto, Takayuki;
    • Rody, Achim;
    • Kelly, Catherine;
    • Müller, Volkmar;
    • Schmidt, Schmidt;
    • Qi, Yuan;
    • Holtrich, Uwe;
    • Becker, Sven;
    • Santarpia, Libero;
    • Fasolo, Angelica;
    • Del Conte, Gianluca;
    • Zambetti, Milvia;
    • Sotiriou, Christos;
    • Haibe-Kains, Benjamin;
    • Symmans, W Fraser;
    • Gianni, Luca
    Publication type:
    journal article
    30

    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251316176
    By:
    • McArthur, Heather L.;
    • Tolaney, Sara M.;
    • Dent, Rebecca;
    • Schmid, Peter;
    • Asselah, Jamil;
    • Liu, Qiang;
    • Meisel, Jane Lowe;
    • Niikura, Naoki;
    • Park, Yeon Hee;
    • Werutsky, Gustavo;
    • Bianchini, Giampaolo;
    • Andersen, Jay C.;
    • Kozarski, Robert;
    • Rokutanda, Nana;
    • Pistilli, Barbara;
    • Loibl, Sibylle
    Publication type:
    Article
    31

    Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.

    Published in:
    2017
    By:
    • Bianchini, Giampaolo;
    • Kiermaier, Astrid;
    • Bianchi, Giulia Valeria;
    • Im, Young-Hyuck;
    • Pienkowski, Tadeusz;
    • Mei-Ching Liu;
    • Ling-Ming Tseng;
    • Dowsett, Mitch;
    • Zabaglo, Lila;
    • Kirk, Sarah;
    • Szado, Tania;
    • Eng-Wong, Jennifer;
    • Amler, Lukas C.;
    • Valagussa, Pinuccia;
    • Gianni, Luca;
    • Liu, Mei-Ching;
    • Tseng, Ling-Ming
    Publication type:
    journal article
    32
    33
    34
    35
    36
    37

    Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.950861
    By:
    • Fabi, Alessandra;
    • Buono, Giuseppe;
    • Bria, Emilio;
    • Bianchini, Giampaolo;
    • Curigliano, Giuseppe;
    • De Laurentiis, Michelino;
    • De Placido, Sabino;
    • Del Mastro, Lucia;
    • Guarneri, Valentina;
    • Generali, Daniele;
    • Livi, Lorenzo;
    • Lorusso, Vito;
    • Montemurro, Filippo;
    • Puglisi, Fabio;
    • Vigneri, Paolo;
    • Zambelli, Alberto;
    • Arpino, Grazia
    Publication type:
    Article
    38

    Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.827625
    By:
    • Ocaña, Alberto;
    • Chacón, Jose Ignacio;
    • Calvo, Lourdes;
    • Antón, Antonio;
    • Mansutti, Mauro;
    • Albanell, Joan;
    • Martínez, María Teresa;
    • Lahuerta, Ainhara;
    • Bisagni, Giancarlo;
    • Bermejo, Begoña;
    • Semiglazov, Vladimir;
    • Thill, Marc;
    • Chan, Arlene;
    • Morales, Serafin;
    • Herranz, Jesús;
    • Tusquets, Ignacio;
    • Chiesa, Massimo;
    • Caballero, Rosalía;
    • Valagussa, Pinuccia;
    • Bianchini, Giampaolo
    Publication type:
    Article
    39

    Real-world use of multigene signatures in early breast cancer: differences to clinical trials.

    Published in:
    Breast Cancer Research & Treatment, 2024, v. 205, n. 1, p. 39, doi. 10.1007/s10549-023-07227-0
    By:
    • Licata, Luca;
    • De Sanctis, Rita;
    • Vingiani, Andrea;
    • Cosentini, Deborah;
    • Iorfida, Monica;
    • Caremoli, Elena Rota;
    • Sassi, Isabella;
    • Fernandes, Bethania;
    • Gianatti, Andrea;
    • Guerini-Rocco, Elena;
    • Zambelli, Claudia;
    • Munzone, Elisabetta;
    • Simoncini, Edda Lucia;
    • Tondini, Carlo;
    • Gentilini, Oreste Davide;
    • Zambelli, Alberto;
    • Pruneri, Giancarlo;
    • Bianchini, Giampaolo
    Publication type:
    Article
    40

    The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 12, p. 2355, doi. 10.1002/1878-0261.13141
    By:
    • Triulzi, Tiziana;
    • Bianchini, Giampaolo;
    • Di Cosimo, Serena;
    • Pienkowski, Tadeusz;
    • Young-Hyuck Im;
    • Bianchi, Giulia Valeria;
    • Galbardi, Barbara;
    • Dugo, Matteo;
    • De Cecco, Loris;
    • Ling-Ming Tseng;
    • Mei-Ching Liu;
    • Bermejo, Begoña;
    • Semiglazov, Vladimir;
    • Viale, Giulia;
    • de la Haba-Rodriguez, Juan;
    • Do-Youn Oh;
    • Poirier, Brigitte;
    • Valagussa, Pinuccia;
    • Gianni, Luca;
    • Tagliabue, Elda
    Publication type:
    Article
    41
    42

    TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

    Published in:
    Molecular Oncology, 2014, v. 8, n. 3, p. 508, doi. 10.1016/j.molonc.2013.12.018
    By:
    • Győrffy, Balázs;
    • Bottai, Giulia;
    • Lehmann-Che, Jacqueline;
    • Kéri, György;
    • Őrfi, László;
    • Iwamoto, Takayuki;
    • Desmedt, Christine;
    • Bianchini, Giampaolo;
    • Turner, Nicholas C.;
    • de Thè, Hugues;
    • André, Fabrice;
    • Sotiriou, Christos;
    • Hortobagyi, Gabriel N.;
    • Di Leo, Angelo;
    • Pusztai, Lajos;
    • Santarpia, Libero
    Publication type:
    Article